Nutex Health Q3: Revenue $78.8M (+26%), Adj EBITDA $13.5M (+938%), Operating income positive

Nutex Health Inc.

2024-Q3 EPS reported -$1.91 revenue$222,330,917

Q3 total revenue $78.8M vs $62.7M YoY (+26%); mature hospitals grew 20.7%.
Operating income $9.7M vs loss of $0.8M; includes $2.0M non-cash stock comp.
Adjusted EBITDA attributable to Nutex $13.5M vs $1.3M (+938% YoY).
Net loss attributable $8.8M (incl. $6.7M non-cash warrant loss) vs $5.5M loss.
Hospital visits 41,668 (+11.3%); nine-month operating cash flow $23.1M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.